Coronavirus

Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

Read the latest on drug pricing

Cost-Based Pricing For Innovative Medicines Is Unviable And Harmful

Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open (JNO). This study wrongly suggests that cost-based pricing accurately values innovative on-patent medicines, distracts from serious policymaking, and fuels political grandstanding by politicians such as Senator Bernie Sanders. Cost-based pricing could be an economically viable pricing ...
Coronavirus

NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immuno­compromised

The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Commentary

Why weakening of intellectual property rules is a threat to California

This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
Commentary

This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.

If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
Coronavirus

PRI Covid Tradeoffs Brief Receives National Coverage

PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review

Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Commentary

Improving The FDA’s Regulatory Process Can Enhance Treatment Options

Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
Coronavirus

NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses

States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Commentary

Nation Past COVID Emergency, Medicaid Needs to Do the Same

With the expiration of the COVID-19 public health emergency, states are finally able to remove people from Medicaid who are not eligible for the program under the law. Some are taking full advantage. A recent analysis by the Kaiser Family Foundation found that at least 565,000 patients in 12 states have been ...
Commentary

Moderna, Pfizer signal they plan to raise price of their shots

In defense of pandemic profits

The price of a COVID-19 shot will soon go up. The federal public health emergency ended this month, and the government will stop providing COVID vaccines to all Americans free of charge. Moderna and Pfizer have both signaled that they plan to raise the prices of their shots once the ...
Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

Read the latest on drug pricing

Cost-Based Pricing For Innovative Medicines Is Unviable And Harmful

Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open (JNO). This study wrongly suggests that cost-based pricing accurately values innovative on-patent medicines, distracts from serious policymaking, and fuels political grandstanding by politicians such as Senator Bernie Sanders. Cost-based pricing could be an economically viable pricing ...
Coronavirus

NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immuno­compromised

The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Commentary

Why weakening of intellectual property rules is a threat to California

This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
Commentary

This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.

If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
Coronavirus

PRI Covid Tradeoffs Brief Receives National Coverage

PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review

Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Commentary

Improving The FDA’s Regulatory Process Can Enhance Treatment Options

Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
Coronavirus

NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses

States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Commentary

Nation Past COVID Emergency, Medicaid Needs to Do the Same

With the expiration of the COVID-19 public health emergency, states are finally able to remove people from Medicaid who are not eligible for the program under the law. Some are taking full advantage. A recent analysis by the Kaiser Family Foundation found that at least 565,000 patients in 12 states have been ...
Commentary

Moderna, Pfizer signal they plan to raise price of their shots

In defense of pandemic profits

The price of a COVID-19 shot will soon go up. The federal public health emergency ended this month, and the government will stop providing COVID vaccines to all Americans free of charge. Moderna and Pfizer have both signaled that they plan to raise the prices of their shots once the ...
Scroll to Top